Yasmine Wasfi's Stock Options and RSUs in Savara Inc
2025-10-22SEC Filing 3 (0002092127-25-000002)
Yasmine Wasfi, Chief Medical Officer of Savara Inc, reported ownership of 155,000 shares of common stock and stock options. The stock options include 110,000 shares exercisable at $4.13, vesting in quarterly installments starting December 4, 2023, and expiring on December 11, 2033. Additionally, 175,000 shares are exercisable at $3.35, vesting in quarterly installments starting December 12, 2024, and expiring on December 12, 2034. Wasfi also holds 80,000 RSUs vesting on December 4, 2025, and 75,000 RSUs vesting on December 12, 2026, contingent on continued service. The filing includes a Limited Power of Attorney for Section 16(a) reporting, authorizing David L. Lowrance and Kathleen R. McCabe to act on Wasfi's behalf.
Tickers mentioned in this filing:SVRA
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1160308/0002092127-25-000002.txt